Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion
NCT00090831 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91
Last updated 2019-12-03
Summary
This study will examine the role of serotonin function in the brain. Serotonin, one of the brain's natural chemicals, connects with receptors on brain cells to regulate emotion, anxiety, sleep, stress hormones, and other body functions that are disturbed in various mood and anxiety disorders. Also, the research will look at the function of particular brain areas, how they are involved in regulating emotions, and how serotonin is involved in the regulation of their function. The procedures entailed are tryptophan depletion and magnetic resonance imagining (MRI). Also, researchers' understanding of the genetic causes of mood and anxiety disorders will increase through examination of participants' DNA.
Adults in good health, ages 20 through 50, may be eligible for this study. Among those not eligible are females who are pregnant or breast feeding, patients with psychiatric or central nervous system disease, and those taking medications that would interfere with study results.
At the first visit, patients will be asked about their general mood, degree of nervousness, thinking skills, and behavior. The session will last from 1.5 to 2.0 hours. A blood sample of about 2 tablespoons will be drawn, for DNA study.
Participants will undergo the following procedures and tests:
* Physical examination.
* Test of vital signs, lying and standing.
* Electrocardiogram.
* Collection of blood for chemistry and hematology.
* Urinalysis.
* HIV, urine drug, and hepatitis screening.
* Psychiatric screening.
* (SqrRoot) -HCG pregnancy test, if applicable.
At the second visit, patients will receive either tryptophan depletion or placebo, and 5 hours later, the study will begin, to last up to 2 additional hours. Patients will be asked periodically about their emotional state or changes in their well-being. The MRI system will create images of the brain's blood flow and measure glucose metabolism as a measure of brain activity. During the MRI scan, patients will hear knocking or beeping sounds, and they will wear earplugs to reduce the noise. Patients will be able to communicate with the MRI staff at all times during the scan, and they may ask to be moved out of the machine at any time. The MRI session lasts up to 1.5 hours.
Results of any medical tests or other information will not be provided to participants, because further research may be needed before such results are meaningful. But if meaningful information develops from this study that may be important for a participant's health, he or she will be notified about it when it becomes available.
Conditions
- Healthy
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Principal Investigators
-
James J Blair, Ph.D. · National Institute of Mental Health (NIMH)
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-08-31
- Completion
- 2012-09-17
Countries
- United States
Study Locations
More Related Trials
-
Mood, Serotonin and Social Interaction
NCT02051530 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder
NCT01313403 ·Status: WITHDRAWN ·Phase: NA
-
The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
NCT00581009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PET Whole Body Distribution Studies Using [11C]CUMI
NCT01132872 ·Status: COMPLETED
-
Depression and Health Outcomes in Refractory Epilepsy
NCT00026637 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Neuropsychological Effects of 5-HT2a Antagonism
NCT07022366 ·Status: RECRUITING ·Phase: NA
-
Sertraline vs. Placebo for Symptoms Following Traumatic Brain Injury
NCT00208585 ·Status: UNKNOWN ·Phase: NA
-
Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
NCT00641108 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects
NCT00001919 ·Status: COMPLETED
-
Treatment of Post-Traumatic Brain Injury (TBI) Depression
NCT00233103 ·Status: COMPLETED ·Phase: PHASE2
-
Mood Effects of Serotonin Agonists Extended
NCT03934710 ·Status: COMPLETED ·Phase: PHASE1
-
Sub-chronic Effects of 5-hydroxytryptophan on Mood and Emotional Processing in Healthy Volunteers
NCT01514409 ·Status: COMPLETED ·Phase: NA
-
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
NCT00125957 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects
NCT00470925 ·Status: TERMINATED ·Phase: PHASE1
-
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
NCT00704379 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Human Cerebral Blood Flow and Serotonin
NCT05957094 ·Status: UNKNOWN ·Phase: NA
-
Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome
NCT00149825 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Peripheral Serotonin Levels in a Control Cohort
NCT06910774 ·Status: COMPLETED
-
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00256113 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Sertraline on Brain Connectivity in Adolescents With OCD
NCT02797808 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Brain Response to Serotonergic Medications in ASD
NCT04145076 ·Status: UNKNOWN ·Phase: NA
-
7T Amygdala and Citalopram Study
NCT06412315 ·Status: RECRUITING ·Phase: NA
-
Depression and Traumatic Brain Injury
NCT00254007 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Sleep Deprivation
NCT05893173 ·Status: COMPLETED
-
Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury
NCT00208572 ·Status: UNKNOWN ·Phase: NA